Congenital hemangiomas that grow rapidly or that threaten a vital organ may now be treated with oral propranol or topical timolol. Details here.
Congenital hemangiomas generally undergo spontaneous resolution; 90% disappear by the time a child reaches age 10. However, removal is indicated if these lesions are growing and/or threatening vital organs.
Treatment options include:
. Oral steroids
. Oral propranolol
. Topical timolol
Kasabach-Merritt syndrome involves the presence of a large congenital hemangioma that destroys platelets and consumes coagulation factors. These lesions appear in the early postpartum period; affected children often have a bleeding diathesis.
Treatment includes:
. Correcting the coagulopathy
. Addressing the tumor (via surgery, embolization, oral propranolol, oral steroids)
For more webinar videos, click here.
Access practical, evidence-based guidance to support better care for our youngest patients. Join our email list for the latest clinical updates.
Andrew Alexis, MD, MPH, highlights positive lebrikizumab-lbkz data for atopic dermatitis
June 25th 2025Lebrikizumab demonstrated efficacy and safety in patients with skin of color and moderate-to-severe atopic dermatitis in the ADmirable trial. Trial investigator Andrew Alexis, MD, MPH, reacts.